The capacity for different lipo-oligosaccharide (LOS) sialylation patterns of Neisseria meningitidis serogroup C to influence the binding and function of the innate humoral component, mannose-binding lectin (MBL), was investigated. By use of flow cytometry and immunogold electron microscopy, a clinical isolate with reduced endogenous LOS sialylation was found to bind more MBL than did strains with higher endogenous sialylation. MBL binding was reduced but not ablated if the same strain was allowed to exogenously sialylate its LOS structures after incubation with cytidine-5 -monophospho-neuraminic acid. MBL binding led to an increased rate of complement activation, with enhanced deposition of the complement components C4 and C5b-9, and this correlated with an increase in bactericidal activity. LOS sialylation appears to be an important determinant of MBL binding to N. meningitidis and can modulate complement-dependent killing of the bacterium. These findings could explain the observed susceptibility to meningococcal disease of individuals genetically deficient in MBL.
mechanisms are operating to protect individuals from this infection before the development of specific antibodies.
Mannose-binding lectin (MBL) is a sugar-binding protein found in the serum of humans and of all mammals studied [5] . It has a specificity defined by the orientation of hydroxyl groups at the 3 and 4 positions around the carbon ring in hexose sugars, with affinity for mannose and N-acetylglucosamine derivatives, and by the spacing and orientation of these sugars on target surfaces [6, 7] . This allows the molecule to discriminate between self and non-self sugar arrays [8] . On binding to its targets, MBL activates the complement system via MBL-associated serine protease (MASP)-1 and MASP-2, of which the latter cleaves C4 and C2 to generate a C3 convertase independently of immunoglobulin [9, 10] . In addition, MBL may interact directly with phagocytic cells to regulate their function [5] .
Serum concentrations of MBL are genetically determined via 3 structural gene mutations and 3 promotor region polymorphisms. Homozygosity for any of the 3 structural mutations reduces the serum level of MBL from a median of 2 mg/mL (homozygous normal) to !0.01 mg/mL. In the heterozygous state, serum levels are also profoundly reduced to ∼0.4 mg/mL. The presence of promotor polymorphisms contributes to the wide range of MBL concentrations observed in all individuals [5] .
It has been reported that the inheritance of structural gene variants of MBL may predispose individuals to meningococcal infection, although this may be more pronounced in younger people [11, 12] . We showed elsewhere [13] that MBL can bind to and activate complement on serogroup B meningococci. Binding was enhanced when the organism was mutated to truncate the lipo-oligosaccharide (LOS) moiety or when the terminal sialic acid residues were removed through enzymatic di-gestion. Meningococcal LOS sialylation has been noted elsewhere as critical in down-regulating complement activation [14, 15] , which is important for meningococcal survival in blood [16] . Sialylation decreases adherence of bacteria to endothelial cells [17] , and LOS immunotypes that cannot be sialylated appear to predominate in nasal carriage strains, whereas most blood isolates carry immunotypes that can be sialylated [18] . It has been shown that sialylation status can differ between different body compartments in the same host [19] , and meningococci possess rapid genetic control mechanisms over expression of this moiety [20] . This suggests that sialic acid may have a complex and changing role in determining invasion of the host, survival in the vascular system, and escape into extravascular sites. Although our previous results suggest that LOS sialylation is an important determinant of MBL binding, the data as yet have been indirect. In this report, we aimed to determine whether natural variation in the LOS sialylation in clinical strains of encapsulated serogroup C influenced MBL binding to the bacterium and how this related to complement activation and the killing of organisms in serum.
Methods
Bacterial strains. N. meningitidis serogroup C strains 7954, 7973, and 8026 are clinical isolate strains that have been described elsewhere [14] . They differ in endogenous sialylation such that, when grown in media lacking cytidine-5 -monophospho-neuraminic acid (CMP-NANA; Sigma), they differ in the extent of LOS sialylation, as determined by a whole cell ELISA: strain 7954, 48% endogenous sialylation; strain 7973, 86% endogenous sialylation; and strain 8026, 4% endogenous sialylation. Strains 7954 and 7973 survive in р25% nonimmune serum, and strain 8026 survives in 0.4% serum [14] .
Strains were removed from Ϫ70ЊC storage in Muller Hinton broth plus 15% vol/vol glycerol, were cultured overnight on gonococcal agar (Difco) supplemented with Vitox (Oxoid) at 37ЊC in 5% CO 2 and then were streaked onto gonococcal agar supplemented or not with 50 mg/mL CMP-NANA. Organisms were cultured for 3.5 h into midlog-phase and then were resuspended in veronal buffered saline (VBS; Oxoid) supplemented with 5 mM CaCl 2 and 5 mM MgCl 2 (VBS ϩϩ ) for MBL-binding studies or VBS supplemented with 10 mM glucose and 5 mM CaCl 2 (VBS-Glc) for killing and complement-activation studies at an absorbance at 540 nm of 1, which corresponds to 10 9 cfu/mL. MBL and 3F11 binding to N. meningitidis. Simultaneous binding of MBL and antibody 3F11 (gift from M. Apicella, University of Iowa, Iowa City) was determined by a modification of a flow cytometric method described elsewhere [13] . MBL was purified from human plasma paste (donated by Clive Dash, Blood Products Laboratory, Elstree, UK) by a 2-step mannan-agarose affinity purification process [21] , followed by positive removal of immunoglobulin, as described elsewhere [22] . MBL purified in this manner contains MASP and can cleave C4, as described elsewhere [22, 23] . Organisms were incubated with 5 mg/mL purified MBL in VBS ϩϩ at 37ЊC for 15 min and then were centrifuged at 2500 g, and the cell pellet was washed with VBS ϩϩ before resuspension in biotinylated monoclonal anti-MBL (clone 131-1; Statens Serum Institut, 5 mg/mL, biotinylated using biotinamidocaproate N-hydroxysuccinimide ester [Sigma] at a ratio of ester to antibody of 7.5:1) and antibody 3F11 (10 mg/mL), a monoclonal IgM that recognizes the lacto-N-neotetraose of nonsialylated meningococci [24, 25] . After a 20-min incubation at 37ЊC, the samples were centrifuged and washed as before and then were resuspended in streptavidin-phycoerythrin (PE)-Cy5 (1:250 dilution in VBS ϩϩ ; Pharmingen) and fluorescein isothiocyanate (FITC)-anti-mouse IgM (1:50 dilution in VBS ϩϩ ; Sigma). The samples were incubated for a further 20 min at 37ЊC and then were centrifuged, were washed, and were fixed in 1% vol/vol formaldehyde and 1% wt/vol glucose in PBS for flow cytometry.
Negative controls were established for MBL binding by the omission of MBL or biotinylated anti-MBL. Negative controls for 3F11 binding were established by the use of a galE mutant of serogroup B (donated by M. Frosch, University of Wü rzburg, Wü rzburg, Germany), which lacks the 3F11 recognition site, and the omission of 3F11 antibody in combination with the serogroup C strains. In certain experiments, the binding of MBL and 3F11 was determined separately, to exclude the possibility of interference between MBL or 3F11 binding and/or detection.
The specificity of MBL binding was determined by the addition of known antagonists of MBL binding, 25 mM N-acetyl-D-glucosamine or 5 mM EDTA, to the MBL preparation 10 min before the addition of lectin to the organisms. Galactose (25 mM), a known nonantagonist, was added to separate samples as a control.
Detection of MBL binding to N. meningitidis C8026 by electron microscopy (EM). Aliquots (1.5 mL) of N. meningitidis C8026 grown with or without CMP-NANA were suspended in MBL (5 mg/mL in VBS ϩϩ ) or in buffer alone (controls) and were incubated at 37ЊC for 30 min. Suspensions were centrifuged at 2500 g for 2.5 min, and the bacterial pellet was washed with 200 mL VBS ϩϩ . Pellets were resuspended in 500 mL mouse anti-MBL (2.5 mg/mL; Statens Serum Institute) and were incubated at 37ЊC for 30 min. Samples were centrifuged and washed as before, were resuspended in 250 mL of 5-nm gold-labeled goat anti-mouse IgG (0.75 mg/mL; British BioCell International), and were incubated at 37ЊC for 30 min. Samples were washed as before and were fixed in 0.5% vol/vol glutaraldehyde in VBS ϩϩ overnight at 4ЊC. Samples were centrifuged as before and were washed twice in distilled water. Pellets were incubated in 1% wt/vol osmium tetroxide for 1 h at 4ЊC and then were washed twice in distilled water. Samples were gradually dehydrated by being incubated sequentially in 70%, 90%, and 100% (twice) vol/vol ethanol for 10 min each and then were incubated in propylene oxide for 10 min (all at room temperature). Samples were incubated in a 50% propylene oxide/50% resin (vol/vol) mix for 15 min at room temperature. Pellets were centrifuged as before and were incubated in resin (47% vol/vol agar 100, 20% vol/vol [2-dodecen-1-yl] succinic anhydride, 30% vol/vol methyl nadic anhydride, and 3% vol/vol 2,4,6-Tris[Dimethylaminomethyl]phenol; Agar Scientific) at 60ЊC overnight.
Ultrathin sections (∼75 nm) were cut, using an ultratome, and were collected onto copper grids pre-etched with 100% acetic acid. Sections were floated on 25% vol/vol uranyl acetate in methanol for 30 min in the dark at room temperature and were washed twice in 100% methanol for 20 s each. Sections then were floated onto Reynolds lead citrate (0.65% wt/vol lead nitrate and 0.85% wt/vol sodium citrate) in a desiccator at room temperature for 30 min. Stained sections were washed in distilled water for 20 s each and were examined in an EM (Joel 120 CX).
To determine whether there were differences in the binding of MBL between sialylated and nonsialylated organisms, photomicrographs of cell sections were randomized and were scored blindly for MBL binding. Sections were scored as negative or positive for MBL binding on the basis of the number of MBL-binding foci noted. A minimum of 100 sections positive for immunogold spots was evaluated in each case, and the results were expressed as percentages, to allow for comparison between different experiments and conditions.
Detection of C4 and C5b-9 binding to N. meningitidis C8026. Aliquots (50 mL) of N. meningitidis C8026 were incubated with 5 mg/mL purified MBL in VBS-Glc for 15 min at 37ЊC. The organisms were centrifuged and washed as described above and then were resuspended in half their original volume in VBS-Glc. To this suspension was added an equal volume of MBL-deficient serum diluted in VBS-Glc to a final concentration of 10% serum. Serum was recovered from an adult genotyped as LYPB/LYPB-that is, homozygous for the B mutation in codon 54 of the MBL gene [26, 27] . This serum was shown to be antigenically deficient in serum MBL by ELISA [28] . Samples were transferred immediately to a water bath at 37ЊC. At various time points, aliquots were removed, and 1 mL of ice-cold Hanks' balanced salt solution (HBSS; Gibco) without Mg 2ϩ or Ca 2ϩ was added. The mixture then was centrifuged, and the cell pellet was washed with HBSS. The bacteria were resuspended in 50 mL of biotinylated anti-C4d (conjugated as described above, 10 mg/mL; Quidel), which recognizes C4, C4b, and C4d, and in FITC-conjugated anti-C5b-9 (conjugated as described elsewhere [29] , 20 mg/mL; Quidel), which recognizes the C9 neoepitope. These samples were incubated at 37ЊC for 20 min and then were centrifuged, and the pellet was washed. The organisms were resuspended in 1:250 streptavidin-PE-Cy5 for 20 min at 37ЊC before they were centrifuged, and the pellet was washed and then was resuspended in 1% vol/vol formaldehyde and 1% wt/vol glucose for flow cytometry. As a control, the same experiment as above was done using MBL-deficient serum that had been heat-inactivated at 56ЊC for 30 min.
The influence of MBL on bactericidal killing of N. meningitidis C8026. Bactericidal assays were performed by a modification of a method described elsewhere [14] . N. meningitidis C8026 were grown with or without CMP-NANA, and aliquots (200 mL) were resuspended in MBL (5 mg/mL in VBS-Glc) or with VBS-Glc alone and were incubated for 15 min at 37ЊC. The organisms were washed and resuspended in half their original volume. To this was added an equal volume of MBL-deficient serum diluted in VBS-Glc, MBL-deficient serum heat-inactivated for 30 min at 56ЊC diluted in VBS-Glc, or VBS-Glc alone. The concentrations of serum used were determined elsewhere to be the highest concentration at which the organisms would survive [14] . For organisms grown in the presence of CMP-NANA, 2% serum was added to give a final concentration of 1%. To organisms grown without CMP-NANA, 1% serum was added to give a final concentration of 0.5%. Organisms were incubated at 37ЊC for 30 min, at which time, duplicate 20-mL aliquots were removed for viable counting by the Miles and Misra serial dilution method. The survival of bacteria in MBLdeficient serum was calculated as a percentage of the survival in heat-inactivated serum.
Statistical techniques. The binding of MBL and 3F11 binding to the 3 different meningococcal strains grown with and without CMP-NANA were compared with each other and with the background staining by use of the Kruskal-Wallis test. The killing of meningococci with and without pretreatment with MBL also was compared, using the Wilcoxon signed-rank test for comparison of 2 related samples.
Results

LOS sialylation influences MBL binding to clinical isolates of
N. meningitidis serogroup C. MBL binding was determined for 3 meningococcal serogroup C strains isolated from patients with invasive disease. Moderate MBL binding, as defined elsewhere [23] , was observed for strain 8026, but little or no binding was seen with strains 7954 or 7973 (figure 1A). To explore whether this difference correlated with differences in endogenous sialylation [14] , we examined the binding of antibody 3F11, which recognizes the lacto-N-neotetraose of nonsialylated meningococcal LOS: 3F11 binding was detected on strain 8026 but not on the other 2 strains (figure 1B). Strain 8026 then was cultured into midlog-phase in the presence of CMP-NANA, to allow for exogenous sialylation of LOS structures. Levels of MBL detected on this organism were markedly reduced ( , Kruskal-Wallis test; figure 2 and P ! .05 figure 3). A concomitant reduction in 3F11 binding also was seen, confirming the expected increase in LOS sialylation after culture with CMP-NANA. This occurred when 3F11 was incubated with or without prior incubation of 8026 with MBL. MBL binding to strains 7954 and 7973 did not alter significantly after growth in the presence of CMP-NANA. MBL binding to 8026 was abrogated by prior incubation with 5 mM EDTA or 25 mM N-acetyl-glucosamine (data not shown), as described elsewhere for lectin domain-mediated attachment [13] .
Immunogold detection of MBL binding to C8026. To gain more information on the deposition of MBL binding to 8026, we used transmission EM with immunogold detection of bound MBL. Using this method, we observed a striking, nonuniform pattern of MBL binding to nonsialylated 8026 (figure 4). The binding was characterized by discrete areas (foci) often containing multiple immunogold particles. It was also of note that, although EM is not truly quantitative, there was a difference in the number of cell sections positive for MBL binding and in the number of foci observed between nonsialylated and sialylated organisms. For the nonsialylated organisms, a maximum of 12 foci were detected per cell section (75 nm), and 66% of cell sections were positive for у1 immunogold foci (5 separate experiments; figure 5 ).
When strain 8026 was grown in the presence of CMP-NANA, the increased sensitivity of EM showed that the binding of MBL, although greatly reduced, was not entirely ablated. There was a maximum of 9 immunogold foci per organism section, which was lower than the number observed with the nonsialylated organism, and the median number of foci also was reduced (0, compared with 1). However, gold particles were still present on 45% of the sections counted.
Complement activation. MBL initiates the lectin pathway of complement activation via its associated serine proteases, MASP-1 and MASP-2 [9, 10] . The capacity for MBL to increase the association of classical or lectin pathway and lytic pathway components with the meningococcal surface was investigated. C4 deposition, as a marker of classical or lectin pathway activation, and C5b-9 deposition, as a marker of membrane attack complex formation (MAC), were determined with strain 8026 after incubation with MBL-deficient serum.
Strain 8026 grown with or without CMP-NANA was preincubated with or without MBL and then was exposed to 10% MBL-deficient serum at 37ЊC. These conditions have been shown elsewhere to be conducive to measuring lectin pathway activation, while reducing classical pathway activation [30] . Organisms were analyzed for surface-bound complement components at various time points.
Deposition of C4 on nonsialylated 8026 was apparent within 1 min of incubation with MBL-deficient serum (figure 6). At this time point, preincubation with MBL did not appear to alter complement activation. However, at 3 min, preincubation with MBL caused a greater proportion of organisms to be associated with both C4 and C5b-9 (70% with MBL, compared with 30% without MBL; figure 6 , upper right quadrants), with a reduced proportion of organisms binding C4 only (figure 6, lower right quadrants). At this time, MBL appeared to have increased the proportion of organisms that had bound MAC (73%, compared with 34%; figure 6 , upper quadrants summated) and increased the proportion of organisms that had bound C4 (87%, compared with 71%; figure 6, right-hand quadrants) . By 5 min, complement deposition in the presence or absence of MBL appeared to be more even, with a similar proportion of organisms binding both C4d and C5b-9 either with or without MBL (figure 6). However, the overall proportion of organisms binding C5b-9 was still increased in the presence of MBL at 5 min (92%), compared with organisms that had not been preincubated with MBL (81%). There appeared to be a tendency for organisms to lose C4d as time progressed, but this did not seem to affect the association of C5b-9.
When strain 8026 was grown with CMP-NANA, there was a profound delay in the association of C4 and C5b-9, irrespective of the presence or absence of MBL. Under these conditions, the association of C4 and C5b-9 after a 20-min incubation with serum was similar to that observed with nonsialylated bacteria at 3 min (figure 7). As seen with nonsialylated organisms, the addition of MBL increased the proportion of bacteria binding both C4d and C5b-9 at this time point. At 40 min, the proportion of organisms double stained with C4d/C5b-9 was largely unchanged for organisms preincubated with MBL, compared with the same organisms at 20 min. In the absence of MBL, the proportions of C4d and C5b-9 double staining increased between 20 and 40 min and were Figure 6 . Association of C4 and C5b-9 with the nonsialylated form of Neisseria meningitidis 8026. Midlog-phase organisms were incubated with mannose-binding lectin (MBL; 5 mg/mL) or buffer alone for 10 min. The organisms were washed and incubated with 10% MBL-deficient serum for short periods of time before the reaction was stopped with ice-cold buffer. Organisms were then double stained with monoclonal antibodies to C4d (phycoerythrin-Cy5 [PE-Cy5]) and C5b-9 (fluorescein isothiocyanate [FITC]) and were analyzed by flow cytometry. Density plots are representative of 5 separate experiments. Panels on the left show results for organisms incubated for 1 min with serum; the upper panel represents organisms not preincubated with MBL, and the lower panel represents organisms that were preincubated. The middle panels represent the same organisms after a 3-min incubation in serum, and panels on the right are for the same organisms after a 5-min incubation. Each density plot was divided into quadrants to determine the proportion of organisms positive for a particular moiety. The percentages in the upper corners of each density plot refer to the proportion of organisms double stained for C4 and C5b-9 (right) or C5b-9 alone (left). The percentages in the bottom corners refer to the proportion of organisms stained for C4 only (right) and those not stained for C4 or C5b-9 (left). similar at the later time point to those observed when MBL was present (figure 7). The loss of C4, which was apparent with the nonsialylated organisms, was not detected with the sialylated organisms, such that organisms fell mainly into those binding just C4 and those binding both C4 and C5b-9. Therefore, the proportion of organisms binding C5b-9 (with or without C4 binding) was increased at 20 min with MBL preincubation (66%), compared with no preincubation (36%), but not at 40 min (65% and 61%, respectively).
It was notable that the maximum intensity of C4 staining was increased on the sialylated organisms, compared with nonsialylated organisms, but the maximum C5b-9 intensity was reduced. The proportion of organisms binding any C5b-9 was also reduced in the sialylated organisms, compared with the nonsialylated organisms either with or without MBL preincubation. With MBL, 92% of nonsialylated organisms had bound C5b-9 at 5 min ( figure 6, upper quadrants summated) , but with sialylation, this was reduced to 65% at 40 min ( figure  7, upper quadrants summated) . Without MBL, 81% of nonsialylated organisms had bound C5b-9 at 5 min, compared with 61% of sialylated organisms at 40 min. The association of C4 and C5b-9 over time with either sialylated or nonsialylated 8026 was not observed with heat-inactivated serum obtained from the same MBL-deficient donor (data not shown).
Killing of N. meningitidis C8026. The killing of meningococci by the formation of the MAC is thought to be of particular importance in immunity to this organism [3, 31] . However, because MBL appeared to predominantly affect the rate of C4d and C5b-9 deposition, it was unclear whether this would translate into enhanced bacterial killing. A modified version of a technique previously used to determine the serum sensitivity of strain 8026 was used to test whether MBL could increase the killing of meningococci [14] . Strain 8026 was incubated with MBL (5 mg/mL) and then was incubated with MBL-deficient serum diluted to 0.5% (organisms grown without CMP-NANA) or 1% (grown with CMP-NANA) or with heat-inactivated MBL-deficient serum for 30 min at 37ЊC. These concentrations of serum had been determined elsewhere to be the minimum dilutions at which the organisms would survive [14] , a finding that was confirmed in this study (data not shown).
Pretreatment with MBL reduced the proportion of bacteria surviving after 30 min for both nonsialylated and sialylated Figure 7 . Association of C4 and C5b-9 with the sialylated form of Neisseria meningitidis 8026. Midlog-phase organisms grown in the presence of cytidine-5 -monophospho-neuraminic acid were incubated with mannose-binding lectin (MBL; 5 mg/mL) or buffer alone for 10 min and then were incubated with 10% MBL-deficient serum and were double stained for C4, using an antibody against C4d (phycoerythrin-Cy5 [PE-Cy5]), and for membrane attack complex, using an antibody against C5b-9 (fluorescein isothiocyanate [FITC] ). Panels on the left show results for organisms incubated for 10 min with MBL-deficient serum; the upper panel represents organisms not preincubated with MBL, and the lower panel represents organisms that were preincubated. The middle panels show results for organisms incubated for 20 min with MBL-deficient serum, and the panels on the right are for the same organisms after a 40-min incubation in the presence of MBL-deficient serum. The results shown for 10 min and those for 20 min and 40 min were from different experiments. Each density plot was divided into quadrants to determine the proportion of organisms positive for a particular moiety. The percentages in the upper corners of each density plot refer to the proportion of organisms double stained for C4 and C5b-9 (right) or C5b-9 alone (left). The percentages in the bottom corners refer to the proportion of organisms stained for C4 only (right) and those not stained for C4 or C5b-9 (left).
(figure 8;
; Wilcoxon signed rank test). However, P ! .03 the effect was more pronounced for the nonsialylated bacteria. There was no significant difference in the viable count due to pretreatment of nonsialylated or sialylated organisms with or without MBL at 0 or 30 min in heat-inactivated serum or at 0 min in MBL-deficient serum ( , Wilcoxon signed rank P 1 .05 test), which indicates little or no MBL-induced aggregation.
Discussion
Despite the high level of meningococcal carriage, only a very low percentage of the population suffers from invasive disease. This indicates that innate host factors may be of importance in protection against infection. Genetically determined deficiency of MBL has been shown to predispose individuals to infection by N. meningitidis [11, 32] . This effect may be more pronounced in younger individuals than in adults [12] , which may explain the absence of an association between lower MBL serum level and meningococcal disease in an earlier study [33] . The mechanisms of MBL-mediated protection have not been elucidated.
In this study, we set out to determine how MBL may be operating to affect susceptibility to meningococcal disease. We investigated 3 encapsulated strains of N. meningitidis serogroup C that differed in levels of endogenous LOS sialylation. We found that MBL binding was detectable only to the strain with the least endogenous LOS sialylation, and this binding was reduced to background levels by growth of the bacteria with CMP-NANA to allow exogenous LOS sialylation. The status of LOS sialylation was confirmed using an antibody that recognizes nonsialylated meningococcal LOS. However, despite the accumulating evidence that LOS sialylation is an important determinant of MBL binding to Neisseria species [13, 29] , the mechanisms appear to be complex. These results confirm previous observations with isogenic mutants of N. meningitidis serogroup B, which demonstrated that the lack of the sialic acid acceptor site or removal of sialic acid by neuraminidase, but not encapsulation, was important in MBL binding [13] . It also confirms data with other organisms, indicating that LPS structure and/or composition is important in determining MBL binding to bacteria [29, 34] . What is clear is that LOS structure and LOS sialylation are critical determinants of MBL binding. Neisseria meningitidis C8026. Organisms were grown with or without cytidine-5 -monophospho-neuraminic acid and then were incubated with MBL (5 mg/mL) or with buffer alone. After being washed, the organisms were incubated with 0.5% (nonsialylated) or 1% (sialylated) MBL-deficient serum for 30 min at 37ЊC. Survival in serum was calculated as a percentage of the survival in the corresponding controls, using serum from the same source that was heat inactivated at 56ЊC for 30 min. The increase in killing at 30 min was determined by subtracting the survival in the presence of MBL from the survival in the absence of MBL (%). The thick line represents the median increase in killing, and the box represents the interquartile range for 6 separate experiments. The increase in killing was significant for both sialylated and nonsialylated variants.
, survival with MBL vs. survival P ! .03 without MBL (Wilcoxon test).
The binding of MBL to strain 8026 was investigated further, using EM with immunogold detection of bound MBL to determine the distribution of the lectin on the organisms. These results showed that MBL did not bind uniformly to the surface of 8026 but instead bound to discrete regions, or foci, on the bacterial surface. This could indicate that either MBL is not recognizing a widely distributed moiety on the outer membrane or that MBL recognizes a moiety that is only presented in an appropriate orientation and density at a few specific sites within the membrane. It was of interest that MBL binding was not detected on all the nonsialylated bacteria, with a third of the organism sections showing no MBL binding. If it were assumed that a 75-nm section is a reasonable sample of the entire bacterium, this suggests that considerable MBL binding heterogeneity exists even in a population of organisms in midlogphase. When strain 8026 was grown in the presence of CMP-NANA, the binding of MBL was below the detection limit of a flow cytometer. The more sensitive ultrastructural examination revealed that a limited number of MBL binding sites remained on 45% of sections. The level of MBL binding required for complete expression of all the functions of MBL is unknown, but this ultrastructural analysis indicates that even sialylated organisms contain some sites capable of binding MBL.
Several possibilities may be considered for MBL binding to N. meningitidis. From the known sugar sequence of the C8026 LOS, the terminal LOS sugar on nonsialylated LOS would be expected to be galactose [35] , to which MBL does not bind [36] . MBL may be targeting other sugars within the LOS molecule or incomplete LOS structures manufactured by this organism, which might be expected to be relatively sparsely distributed. Alternatively, MBL could be binding to other glycosylated structures in the outer membrane. N. meningitidis does glycosylate its pili [37] , but the sugars added (galactose) should not bind MBL, and other glycosylated outer membrane proteins have not been identified for this organism. It has been suggested recently that MBL may bind to certain peptide targets that mimic sugar ligands, and binding can be inhibited by monosaccharides and EDTA [38] .
We suggest that, to influence susceptibility to meningococcal disease, a likely mechanism would be that MBL would have to be able to activate complement and increase MAC formation, to kill meningococci. Serum bactericidal activity appears to be relatively much more important than neutrophils in killing meningococci [31, 39] . The MBL purified as described above will be associated with activated MASP and will have the potential to cleave C4 and C2 to initiate assembly of C4b2a, the C3 convertase of the classical and lectin pathways. We therefore investigated the influence of MBL and MASP on the activation of complement in MBL-deficient serum, in a manner similar to that described elsewhere [40] , but using flow cytometric detection of activated complement components. Strain 8026 was preincubated with MBL and MASP, to preclude the activation of complement by activated MASP away from the surface of the bacteria (O. Neth, D. L. Jack, N. J. Klein, M. W. Turner, unpublished observations).
The activation of C4 and C5b-9 on 8026 was markedly delayed by sialylation of LOS. This is consistent with the previous description of increased serum resistance of this organism after sialylation [14] . However, this was thought to be due to downregulation of alternative pathway activation [15] . In this study, we have provided data to indicate that sialylation also downregulates the rate of MBL-mediated complement activation and that MBL alters the kinetics of complement activation on both sialylated and nonsialylated organisms. On nonsialylated organisms, MBL increased the rate of deposition of C4, and this appeared to be connected to an increase in the rate of acquisition of C5b-9, even though the maximum intensity of C4 deposition with or without MBL appeared to be similar. At 5-min incubation with MBL-deficient serum, although C4 deposition had evened out between organisms preincubated with or without MBL or MASP, there was still an increased proportion of organisms binding C5b-9. It is intriguing there was evidence that C4 was being lost from the surface of the nonsialylated organisms ( figure 6 ). The antibody against C4 that we used in this study is directed against the C4d fragment of C4, which should have allowed the detection of both C4b and C4d fragments attached to the surface. The C4d fragment should remain covalently attached after the loss of C4c [41] , but this did not appear to be the case. This could be an artefact associated with bacterial cell death or could be the result of further proteolytic cleavage or loss of outer membrane into the supernatant [42] . However, this phenomenon did not occur with sialylated organisms and therefore may reflect the influence of LOS sialylation on complement processing [43] [44] [45] .
Sialylation may affect lectin pathway activation through several possible mechanisms. As we have shown in this report, sialylation reduces the total levels of MBL and influences the distribution on the surface of the organism. This will influence the kinetics of complement activation. However, MBL could also modify complement processing by altering the recruitment of complement regulatory molecules. Support for this comes from our observation that, despite higher levels of C4 deposited on sialylated relative to nonsialylated organisms, the intensity (MFI) of C5b-9 was actually reduced on sialylated bacteria. This was also observed in the absence of MBL, although C5b-9 acquisition was delayed, compared with that seen in the presence of MBL. MBL itself has been shown to modulate complement activation regulation at a number of points, including alternative pathway regulation through the recruitment of C-reactive protein [46] and alterations in the affinities of C4 binding protein and Factor H for their ligands [47, 48] . It is not possible from this study to determine at which level this may occur (C4, C3, or later) since the use of anti-C4d should detect all covalently bound fragments of C4, including those able to form a C3 convertase and those that could not. However, the importance of the alternative pathway in complement-dependent killing would be expected to be rather low at such high serum dilutions. Further studies will be required to elucidate the exact mechanisms involved in MBLcomplement activation kinetics.
We next considered whether the increased rate of complement activation due to MBL could result in increased serum bactericidal activity. We used a modified version of a method published elsewhere [14] to determine changes in serum sensitivity. At low concentrations of MBL-deficient serum, the lectin increased the proportion of both sialylated and nonsialylated organisms killed by serum after 30 min. There was an apparent link between the rate of C5b-9 acquisition and the proportion of organisms killed. Nonsialylated organisms incubated with MBL exhibited the fastest rate of complement activation and most killing, whereas sialylated organisms without MBL had the slowest rate of complement activation and the least killing even at a higher serum concentration. We presume that aggregation was not occurring under these circumstances because there was no difference in viable count between organisms incubated with or without MBL in heat-inactivated serum.
The ability of MBL to increase killing in such dilute serum is perhaps surprising. However, the use of low serum concentrations was shown elsewhere to increase the discrimination between classical and lectin pathway complement activation [30] . Furthermore, the bactericidal potency of even small amounts of MBL has been demonstrated for Salmonella enterica serovar Typhimurium. MBL at log 2 dilutions of 7.7 of normal mouse serum levels was sufficient to kill bacteria with complement [34] . It is presumed that MBL is one of the factors that is required for murine resistance to Ra-chemotype and Ralike strains of S. enterica serovar Typhimurium [49] . It should also be noted that there was no removal of immunoglobulin specific for meningococcus from the serum used in this study, which emphasizes the potential for MBL to assist in immune responses even in adult hosts.
Our results indicate that MBL can bind to encapsulated N. meningitidis serogroup C, particularly if the LOS is nonsialylated. It has been suggested that meningococcal LOS sialylation is important in regulating binding of these bacteria to epithelial and endothelial surfaces [16, 18] and that the organism may go through stages of being relatively less sialylated during pathogenesis [20] . Our data suggest that, once MBL has bound to its targets, the activation of complement is accelerated, leading to increased killing. However, even low-level binding of MBL may be important since we have evidence that this enhances killing of sialylated strains and may influence other functions, such as modulation of inflammatory responses [50] . We suggest that MBL may have a significant influence on the host response to infections by N. meningitidis.
